Disc Historical Valuation

IRON Stock   52.49  0.30  0.57%   
Some fundamental drivers such as market cap or Disc Medicine enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze Disc Medicine valuation indicators such as Enterprise Value of 879.5 M to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of Disc Medicine's future value.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Disc Medicine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in Disc Stock, please use our How to Invest in Disc Medicine guide.

About Disc Valuation Data Analysis

Valuation is the financial process of determining what Disc Medicine is worth. Disc Medicine valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. Disc Medicine valuation ratios help investors to determine whether Disc Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Disc with respect to the benefits of owning Disc Medicine security.

Disc Medicine Valuation Data Chart

As of the 26th of March 2025, Market Cap is likely to grow to about 1.2 B. Also, Enterprise Value is likely to grow to about 879.5 M

Working Capital

The difference between a company's current assets and current liabilities, indicating the liquidity and operational efficiency of the business.

Enterprise Value

Enterprise Value (or EV) is usually referred to as Disc Medicine theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Disc Medicine debt, but would also pocket its cash. Enterprise Value is more accurate representation of Disc Medicine value than its market capitalization because it takes into account all of Disc Medicine existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Pair Trading with Disc Medicine

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Disc Medicine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Disc Medicine will appreciate offsetting losses from the drop in the long position's value.

Moving together with Disc Stock

  0.73CDIOW Cardio DiagnosticsPairCorr
  0.76ELVN Enliven TherapeuticsPairCorr

Moving against Disc Stock

  0.89GE GE AerospacePairCorr
  0.87WM Waste ManagementPairCorr
  0.79LUCD Lucid DiagnosticsPairCorr
  0.78PLX Protalix BiotherapeuticsPairCorr
  0.35PG Procter GamblePairCorr
The ability to find closely correlated positions to Disc Medicine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Disc Medicine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Disc Medicine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Disc Medicine to buy it.
The correlation of Disc Medicine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Disc Medicine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Disc Medicine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Disc Medicine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Disc Medicine offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Disc Medicine's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Disc Medicine Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Disc Medicine Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Disc Medicine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in Disc Stock, please use our How to Invest in Disc Medicine guide.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Disc Medicine. If investors know Disc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Disc Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.96)
Return On Assets
(0.19)
Return On Equity
(0.28)
The market value of Disc Medicine is measured differently than its book value, which is the value of Disc that is recorded on the company's balance sheet. Investors also form their own opinion of Disc Medicine's value that differs from its market value or its book value, called intrinsic value, which is Disc Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Disc Medicine's market value can be influenced by many factors that don't directly affect Disc Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Disc Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Disc Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Disc Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.